分化型甲状腺癌药物治疗现状研究  

Study on the current situation of drug therapy for differentiated thyroid cancer

作　　者：范晓瑞 徐文健 苗良壮 鲁稳 闫晨名 高强[1] 韩勇[1] FAN Xiaorui;XU Wenjian;MIAO Liangzhuang;LU Wen;YAN Chenming;GAO Qiang;HAN Yong(Binzhou Medical University Hospital,Binzhou 256603,China)

机构地区：[1]滨州医学院附属医院,山东滨州256603

出　　处：《临床医学研究与实践》2024年第20期190-193,共4页Clinical Research and Practice

摘　　要：甲状腺癌(TC)是常见的内分泌肿瘤,目前针对该病治疗仍以手术为主。除常规手术治疗外,常见的TC药物治疗手段包括放射性碘治疗(RAIT)、分子靶向药物治疗、促甲状腺激素(TSH)抑制治疗、新辅助化疗以及中医治疗等。本文旨在综述分化型甲状腺癌(DTC)药物治疗的研究现状,以为其治疗思路提供借鉴。Thyroid cancer(TC)is a common endocrine tumor.At present,surgery is still the main treatment for this disease.In addition to conventional surgical treatment,common TC drug treatments include radioactive iodine therapy(RAIT),molecular targeted drug therapy,thyroid stimulating hormone(TSH)inhibition therapy,neoadjuvant chemotherapy,and traditional Chinese medicine treatment,etc.This article aims to review the research status of drug therapy for differentiated thyroid cancer(DTC),so as to provide reference for its treatment ideas.

关 键 词：分化型甲状腺癌 药物治疗 分子机制 副作用 

分 类 号：R736.1[医药卫生—肿瘤]